Dendreon Announces Presentation of PROVENGE(R) (sipuleucel-T) Data at the …

Published May 31, 2013

Dendreon Announces Presentation of PROVENGE(R) (sipuleucel-T) Data at the …

Filed under: drug treatment programs in nyc

Dendreon's first product, PROVENGE(R) (sipuleucel-T), was approved by the U.S. Food and Drug Administration (FDA) in April 2010. Dendreon is exploring the application of additional ACI product candidates and small molecules for the potential treatment …
Read more on Wall Street Journal (press release)

Surprising marijuana moments in (mostly) American culture

Filed under: drug treatment programs in nyc

The Huffington Post story (13 Key Moments In Marijuana History) reported: ''This landmark verdict compelled the Food and Drug Administration to establish a 'Compassionate IND [Investigational New Drug] Program,' which continues to distribute … The …
Read more on San Antonio Express

Nektar Therapeutics' President and CEO, Howard W. Robin, To Present at the …

Filed under: drug treatment programs in nyc

SAN FRANCISCO, May 30, 2013 — /PRNewswire/ — Nektar Therapeutics' (Nasdaq: NKTR) President and Chief Executive Officer, Howard W. Robin, is scheduled to present at the upcoming 2013 Jefferies Global Healthcare Conference in New York at the Grand …
Read more on Sacramento Bee